StaphAseptic First Aid Bactericide Gel
Helps prevent skin infections caused by antibiotic resistant staph (MRSA) and other germs.
 

 
 
 
 
 
 
 
 


Bookmark and Share


 
News

StaphAseptic™ News

Virulent Strain of MRSA Resists Treatment

November 2, 2009

Atlanta Journal-Constitution

SUNDAY, Nov. 1 (HealthDay News) -- New research holds bad news for health officials worried about a potentially lethal infection called MRSA that haunts hospitals: A strain that infects the bloodstream is five times more deadly than other strains.

To make matters worse, the USA600 strain appears to be at least partially immune to an antibiotic that's used to treat the condition, the researchers have found.

A full half of patients infected with the strain died within a month, according to a study scheduled to be presented at the annual meeting of the Infectious Diseases Society of America, held Oct. 29 to Nov. 1 in Philadelphia. That's nearly five times the death rate of other people infected with MRSA, and 10 to 30 percent of those who acquire MRSA infections in the bloodstream die within a month, the study found.

This is a portion of the original article. To read the entire article, visit ajc.com


TecLabs® HOME | PRODUCT INFORMATION | MRSA FAQ | NEWS | WHERE TO BUY | CONTACT US | SITE MAP
Tec Laboratories Inc., 1-800-482-4464

Website design by Feynman Group